MannKind completes direct public offering

MannKind Corp. (NASDAQ:MNKD; Tel Aviv:MNKD), Valencia, Calif. Business: Endocrine/Metabolic, Cancer Date completed: 2015-11-12 Type: Direct public offering Raised: $36.2 million Shares: 13.9 million P...